November 10/2015
Europe
Healthcare Spending: Breaking Out of Best Practice
A new specialist group appointed by the European Commission, the 'Expert panel on effective ways of investing in health', has been reflecting on alternative ways of responding to the challenges of healthcare spend, and is urging more radical solutions based on theories of disruptive innovation. Reflector reports ... / Read more / |
|
Logistics
The Push for a Pull Supply Chain
Experts warn that if pharma doesn’t take a tighter grip on its supply chain and yank it into the 21st century, the industry could soon face distribution and logistics crises on an unprecedented scale ...
/ Read more / |
Deals
Pharma Boards in the Era of Hostile Takeovers
If during a company acquisition there is a lack of honest communication, both businesses lose momentum in months of internal wrangling and realignments – thus jeopardizing the value of the deal itself. What can pharma boards do to help, asks Mike Straw ...
/ Read more / |
Special Feature
Pharm Exec's 2016 Pipeline Report
Falling enterprise values and the drug pricing controversy have defined the life sciences landscape during the waning days of 2015. Will a pipeline harvest full of treatments founded on strong science, supportive regulation, and unmet medical need offer solace to shareholders and the promise of a reputational rebound? ...
/ Read more / |
Digital Health
New Directions in eHealth
PharmExec speaks to Donato Tramuto about how companies like Physicians Interactive are facilitating the interaction between physicians and pharma in the digital age, and to ascertain what he sees as the key trends shaping the immediate future of e-health ...
/ Read more / |
industry update
• |
Galapagos NV (Mechelen, Belgium) announced the appointment of Dr. Christine Mummery to its Board of Directors as an independent non-executive director. |
• |
Biopharmaceutical company F-star (Cambridge, UK) announced the appointment of Dr. Neil Brewis as Chief Scientific Officer. |
• |
ICON (Dublin, Ireland) announced two new leadership appointments to its Asia Pacific operations. Mary Pan has been appointed Vice President, Asia Pacific, and Hiroshi Ichikawa has been appointed Vice President and General Manager of ICON’s operations in Japan.
|
• |
Recipharm (Ashton-under-Lyne, UK) appointed Franco Boselli as Business Director for Italy and Bernard Pluta as General Manager for the operating company in Pessac, France. |
|
|
|